Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) [Phase 2]
This notice reports the completion of a Phase 2 study of SKI-O-703, a SYK inhibitor, in persistent and chronic immune thrombocytopenia and t…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Safety Study of AMG 531 in Japanese Subjects With ITP [Phase 2]
Phase 2 safety study of romiplostim (AMG 531) in Japanese subjects with immune thrombocytopenia has completed. The study evaluated thrombocy…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347 [Phase 1]
This first-in-human Phase 1 trial of PF-06755347 evaluating safety, tolerability, and pharmacokinetics was terminated, and results have been…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies [Phase 2, Phase 3]
Clinical trial update investigating combining thrombopoietin receptor agonists with an anti-CD20 antibody for adults with immune thrombocyto…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP [NA]
A recruiting study evaluating hydroxychloroquine plus dexamethasone for immune thrombocytopenia with positive ANA antibodies.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP [NA]
A clinical trial is evaluating the efficacy and safety of hydroxychloroquine plus prednisone in ANA-positive immune thrombocytopenia; recrui…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP [NA]
A recruiting trial evaluating the efficacy and safety of hydroxychloroquine plus a thrombopoietin receptor agonist in ANA-positive immune th…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination [Phase 2]
This Phase 2 trial investigates a thrombopoietin receptor agonist (TPO-RA) to induce immune tolerance in patients with immune thrombocytopen…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients [Phase 3]
Phase 3 study evaluating safety and immunogenicity of long-term GNR-069 therapy in immune thrombocytopenia has completed.
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010
This observational study assesses outcomes in patients with primary immune thrombocytopenia who underwent splenectomy after 2010; the trial …
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Huaiqihuang Granule in children with chronic primary immune thrombocytop…
-
CLINICAL_TRIALS other · 2024-05-29Clinical Trial Update: The PROLONG Trial - Rituximab Maintenance Therapy in ITP [Phase 3]
A Phase 3 trial update for the PROLONG study evaluating rituximab as maintenance therapy in immune thrombocytopenia; current status is unkno…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: Biologic Characterization of Patients With ITP [NA]
This clinical trial update describes biologic characterization of patients with immune thrombocytopenia (ITP); the study is currently recrui…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
A preliminary Phase 1 study is planned to evaluate UTAA09 injections for relapsed/refractory autoimmune diseases, with recruitment not yet s…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe
A European clinical trial evaluating thrombopoietin receptor agonists for adults with primary immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Short-course High-dose Prednisone and Dexamethasone in Children With ITP [Phase 4]
Phase 4 trial in children with immune thrombocytopenia evaluating a short course of high-dose prednisone and dexamethasone; the study is cur…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children [Phase 4]
A Phase 4 clinical trial is evaluating two intravenous immunoglobulin regimens for newly diagnosed immune thrombocytopenia in children; the …
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of Orelabrutinib in adults with chronic immune thrombocytopenia and is curren…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) [Phase 1, Phase 2]
This clinical trial update evaluates the pharmacokinetics and pharmacodynamics of romiplostim in patients with immune thrombocytopenia (ITP)…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of romiplostim in adults with persistent or chronic immune thrombocytopenia…
-
FDA approval · 2024-04-18FDA Approved: ELTROMBOPAG — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for a generic eltrombopag (eltrombopag olamine).
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: The DART Study- Daratumumab Treatment in ITP [Phase 2]
Phase 2 clinical trial evaluating daratumumab for immune thrombocytopenia (ITP) is ongoing with status unknown.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura [Phase 2]
Phase 2 trial update evaluating eltrombopag with pulsed dexamethasone for immune thrombocytopenia (idiopathic thrombocytopenic purpura) has …
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP) [Phase 2]
This Phase 2a trial of BIVV020 in adults with persistent or chronic immune thrombocytopenia has completed, with results posted in February 2…
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 trial of Rozanolixizumab in persistent or chronic primary immune thrombocytopenia was terminated; results posted in 2024.